Molecular insight into heart development and congenital heart disease: An update review from the Arab countries

Trends in Cardiovascular Medicine

Volumn 25, Issue 4, 2015, Pages 291-301

  Aburawi, Elhadi H ^a   Aburawi, Hanan E ^a   Bagnall, Keith M ^b   Bhuiyan, Zahurul A ^c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR TBX5; GENETIC MARKER;

ANEUPLOIDY; ARAB; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CONGENITAL HEART MALFORMATION; CONSANGUINEOUS MARRIAGE; CONSANGUINITY; COPY NUMBER VARIATION; GENE MUTATION; GENETIC PROCEDURES; GENETIC RISK; GENETIC SCREENING; HEART DEVELOPMENT; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MONOSOMY; POPULATION GROWTH; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; TRISOMY; DOWN SYNDROME; GENETIC MARKER; GENETICS; HEART DEFECTS, CONGENITAL; INCIDENCE; MUTATION; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; UNITED ARAB EMIRATES;

DOWN SYNDROME; GENETIC MARKERS; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; MUTATION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UNITED ARAB EMIRATES;

EID: 84928755831     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.11.007     Document Type: Review

References (115)

1. Mitchell S.C., Korones S.B., Berendes H.W. Congenital heart disease in 56,109 live births. Incidence and natural history. Circulation 1971, 43:323-332.
2. Kerrebijn K.F. Incidence in infants and mortality from congenital malformations of the circulatory system. Acta Paediatr Scand 1966, 55:316-320.
3. Pierpont M.E., Basson C.T., Benson D.W., Gelb B.D., Giglia T.M., Goldmuntz E., et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007, 115:3015-3038.
4. Hoffman J.I.E., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
5. Kliegman RM, Stanton BMD, Geme JS, Schor N, Behrman RE, eds. Nelson textbook of pediatrics, 19th ed. ISBN: 9781437707557, Philadelphia, PA 19103-2899, USA.
6. Petersen S., Peto V., Rayner M. Congenital heart disease statistics 2003, British Heart Foundation Health Promotion Research Group, Department of Public Health, University of Oxford, ISBN 10: 1899088210, United Kingdom.
7. Al-Mesned A., Al Akhfash A.A., Sayed M. Incidence of severe congenital heart disease at the province of Al-Qassim, Saudi Arabia. Congenit Heart Dis 2012, 7:277-282.
8. Chehab G., Chedid P., Saliba Z., Bouvagnet P. Congenital cardiac disease and inbreeding: specific defects escape higher risk due to parental consanguinity. Cardiol Young 2007, 17:414-422.
9. Becker S.M., Al Halees Z., Molina C., Paterson R.M. Consanguinity and congenital heart disease in Saudi Arabia. Am J Med Genet 2001, 99:8-13.
10. Van Praagh S., Truman T., Firpo A., Bano-Rodrigo A., Fried R., McManus B., et al. Cardiac malformations in trisomy-18: a study of 41 postmortem cases. J Am Coll Cardiol 1989, 13:1586-1597.
11. Musewe N.N., Alexander D.J., Teshima I., Smallhorn J.F., Freedom R.M. Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 1990, 15:673-677.
12. Blue G.M., Kirk E.P., Sholler G.F., Harvey R.P., Winlaw D.S. Congenital heart disease: current knowledge about causes and inheritance. Med J Aust 2012, 197:155-159.
13. Nora J.J. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circulation 1968, 38:604-617.
14. Laugwitz K.L., Moretti A., Caron L., Nakano A., Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 2008, 135:193-205.
15. Brade T., Pane L.S., Moretti A., Chien K.R., Laugwitz K.L. Embryonic heart progenitors and cardiogenesis. Cold Spring Harb Perspect Med 2013, 3:a013847.
16. Sylva M., van den Hoff M.J., Moorman A.F. Development of the human heart. Am J Med Genet A 2014, 164A:1347-1371.
17. Showell C., Binder O., Conlon F.L. T-box genes in early embryogenesis. Dev Dyn 2004, 229:201-218.
18. Botto L.D., May K., Fernhoff P.M., Correa A., Coleman K., Rasmussen S.A., et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003, 112:101-107.
19. Yunis K., Mumtaz G., Bitar F., Chamseddine F., Kassar M., Rashkidi J., et al. Consanguineous marriage and congenital heart defects: a case-control study in the neonatal period. Am J Med Genet A 2006, 140:1524-1530.
20. Gev D., Roguin N., Freundlich E. Consanguinity and congenital heart disease in the rural Arab population in northern Israel. Hum Hered 1986, 36:213-217.
21. Jaber L., Merlob P., Bu X., Rotter J.I., Shohat M. Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet 1992, 44:1-6.
22. Bener A., Abdulrazzaq Y.M., al-Gazali L.I., Micallef R., al-Khayat A.I., Gaber T. Consanguinity and associated socio-demographic factors in the United Arab Emirates. Hum Hered 1996, 46:256-264.
23. Hegazy I.S., Al-Beyari T.H., Al-Amri A.H., Qureshi N.A., Abdelgadir M.H. Congenital malformations in primary health care in Al-Qassim region. Ann Saudi Med 1995, 15:48-53.
24. Waller D.K., Shaw G.M., Rasmussen S.A., Hobbs C.A., Canfield M.A., Siega-Riz A.M., et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 2007, 161:745-750.
25. Badran M., Laher I. Type II diabetes mellitus in Arabic-speaking countries. Int J Endocrinol 2012, 2012:902873.
26. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium. 5th ed. ; 2011. http://www.idf.org/diabetesatlas.
27. Wren C., Birrell G., Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003, 89:1217-1220.
28. Abu-Sulaiman R.M., Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol 2004, 25:137-140.
29. Aburawi E.H. Call for multinational studies of the epidemiology of congenital heart disease in the Arab world. Ibnosina J Med Biomed Sci 2013, 5:1-3.
30. Stevens K.N., Hakonarson H., Kim C.E., Doevendans P.A., Koeleman B.P., Mital S., et al. Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PLoS One 2010, 5:e10855.
31. Osoegawa K., Schultz K., Yun K., Mohammed N., Shaw G.M., Lammer E.J. Haploinsufficiency of insulin gene enhancer protein 1 (ISL1) is associated with d-transposition of the great arteries. Mol Genet Genomic Med 2014, 2:341-351.
32. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
33. Okubo A., Miyoshi O., Baba K., Takagi M., Tsukamoto K., Kinoshita A., et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 2004, 41:e97.
34. Baban A., Postma A.V., Marini M., Trocchio G., Santilli A., Pelegrini M., et al. Identification of TBX5 mutations in a series of 94 patients with Tetralogy of Fallot. Am J Med Genet A 2014, [Epub ahead of print]. 10.1002/ajmg.a.36783.
35. Postma A.V., van de Meerakker J.B., Mathijssen I.B., Barnett P., Christoffels V.M., Ilgun A., et al. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008, 102:1433-1442.
36. Benson D.W., Silberbach G.M., Kavanaugh-McHugh A., Cottrill C., Zhang Y., Riggs S., et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 1999, 104:1567-1573.
37. Hiroi Y., Kudoh S., Monzen K., Ikeda Y., Yazaki Y., Nagai R., et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001, 28:276-280.
38. Durocher D., Charron F., Warren R., Schwartz R.J., Nemer M. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J 1997, 16:5687-5696.
39. Singh M.K., Li Y., Li S., Cobb R.M., Zhou D., Lu M.M., et al. Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice. J Biol Chem 2010, 285:1765-1772.
40. Mohan R.A., van Engelen K., Stefanovic S., Barnett P., Ilgun A., Baars M.J., et al. A mutation in the Kozak sequence of GATA4 hampers translation in a family with atrial septal defects. Am J Med Genet A 2014, [Epub ahead of print]. 10.1002/ajmg.a.36703.
41. Kasahara H., Lee B., Schott J.J., Benson D.W., Seidman J.G., Seidman C.E., et al. Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 2000, 106:299-308.
42. Li Q., Pan H., Guan L., Su D., Ma X. CITED2 mutation links congenital heart defects to dysregulation of the cardiac gene VEGF and PITX2C expression. Biochem Biophys Res Commun 2012, 423:895-899.
43. Yagi H., Furutani Y., Hamada H., Sasaki T., Asakawa S., Minoshima S., et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003, 362:1366-1373.
44. Gu H., Smith F.C., Taffet S.M., Delmar M. High incidence of cardiac malformations in connexin40-deficient mice. Circ Res 2003, 93:201-206.
45. Makita N., Seki A., Sumitomo N., Chkourko H., Fukuhara S., Watanabe H., et al. A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol 2012, 5:163-172.
46. Gollob M.H., Jones D.L., Krahn A.D., Danis L., Gong X.Q., Shao Q., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006, 354:2677-2688.
47. Abraham R.L., Yang T., Blair M., Roden D.M., Darbar D. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol 2010, 48:181-190.
48. French V.M., van de Laar I.M., Wessels M.W., Rohe C., Roos-Hesselink J.W., Wang G., et al. NPHP4 variants are associated with pleiotropic heart malformations. Circ Res 2012, 110:1564-1574.
49. Becker-Heck A., Zohn I.E., Okabe N., Pollock A., Lenhart K.B., Sullivan-Brown J., et al. The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation. Nat Genet 2011, 43:79-84.
50. Tariq M., Belmont J.W., Lalani S., Smolarek T., Ware S.M. SHROOM3 is a novel candidate for heterotaxy identified by whole exome sequencing. Genome Biol 2011, 12:R91.
51. Perles Z., Cinnamon Y., Ta-Shma A., Shaag A., Einbinder T., Rein A.J., et al. A human laterality disorder associated with recessive CCDC11 mutation. J Med Genet 2012, 49:386-390.
52. Penton A.L., Leonard L.D., Spinner N.B. Notch signaling in human development and disease. Semin Cell Dev Biol 2012, 23:450-457.
53. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
54. High F.A., Jain R., Stoller J.Z., Antonucci N.B., Lu M.M., Loomes K.M., et al. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J Clin Invest 2009, 119:1986-1996.
55. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., et al. Mutations in the human Jagged gene are responsible for Alagille syndrome. Nat Genet 1997, 16:235-242.
56. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., et al. Spinner NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the Notch signaling pathway. Am J Hum Genet 2006, 79:169-173.
57. Lepri F.R., Scavelli R., Digilio M.C., Gnazzo M., Grotta S., Dentici M.L., et al. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Med Genet 2014, 15:14.
58. Thienpont B., Zhang L., Postma A.V., Breckpot J., Tranchevent L.C., Van Loo P., et al. Haploinsufficiency of Table2 causes congenital heart defects in humans. Am J Hum Genet 2010, 86:839-849.
59. Postma A.V., van Engelen K., van de Meerakker J., Rahman T., Probst S., Baars M.J., et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet 2011, 4:43-50.
60. Natoli G. Maintaining cell identity through global control of genomic organization. Immunity 2010, 33:12-24.
61. Zaidi S., Choi M., Wakimoto H., Ma L., Jiang J., Overton J.D., et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013, 498:220-223.
62. Robinson S.W., Morris C.D., Goldmuntz E., Reller M.D., Jones M.A., Steiner R.D., et al. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 2003, 72:1047-1052.
63. Maslen C.L., Babcock D., Robinson S.W., Bean L.J., Dooley K.J., Willour V.L., et al. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am J Med Genet A 2006, 140:2501-2505.
64. Ackerman C., Locke A.E., Feingold E., Reshey B., Espana K., Thusberg J., et al. An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet 2012, 91:646-659.
65. Niihori T., Aoki Y., Narumi Y., Neri G., Cavé H., Verloes A., et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 2006, 38:294-296.
66. Martinelli S., De Luca A., Stellacci E., Rossi C., Checquolo S., Lepri F., et al. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet 2010, 87:250-257.
67. Aoki Y., Niihori T., Narumi Y., Kure S., Matsubara Y. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008, 29:992-1006.
68. Rodriguez-Viciana P., Tetsu O., Tidyman W.E., Estep A.L., Conger B.A., Cruz M.S., et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 2006, 311:1287-1290.
69. Kamath B.M., Bauer R.C., Loomes K.M., Chao G., Gerfen J., Hutchinson A., et al. NOTCH2 mutations in Alagille syndrome. J Med Genet 2012, 49:138-144.
70. Cirstea I.C., Kutsche K., Dvorsky R., Gremer L., Carta C., Horn D., et al. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 2010, 42:27-29.
71. Razzaque M.A., Nishizawa T., Komoike Y., Yagi H., Furutani M., Amo R., et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 2007, 39:1013-1017.
72. Cordeddu V., Di Schiavi E., Pennacchio L.A., Ma'ayan A., Sarkozy A., Fodale V., et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 2009, 41:1022-1026.
73. Tartaglia M., Pennacchio L.A., Zhao C., Yadav K.K., Fodale V., Sarkozy A., et al. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 2007, 39:75-79.
74. Kalsoom U.E., Wasif N., Tariq M., Ahmad W. A novel missense mutation in the EVC gene underlies Ellis-van Creveld syndrome in a Pakistani family. Pediatr Int 2010, 52:240-246.
75. Dierssen M., Herault Y., Estivill X. Aneuploidy: from a physiological mechanism of variance to Down syndrome. Physiol Rev 2009, 89:887-920.
76. Sailani M.R., Makrythanasis P., Valsesia A., Santoni F.A., Deutsch S., Popadin K., et al. The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndrome. Genome Res 2013, 23:1410-1421.
77. Goldmuntz E., Clark B.J., Mitchell L.E., Jawad A.F., Cuneo B.F., Reed L., et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998, 32:492-498.
78. Rauch R., Hofbeck M., Zweier C., Koch A., Zink S., Trautmann U., et al. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet 2010, 47:321-331.
79. Gong W., Gottlieb S., Collins J., Blescia A., Dietz H., Goldmuntz E., et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 2001, 38:E45.
80. Lammer E.J., Chak J.S., Iovannisci D.M., Schultz K., Osoegawa K., Yang W., et al. Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol 2009, 85:30-35.
81. Thienpont B., Mertens L., de Ravel T., Eyskens B., Boshoff D., Maas N., et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007, 28:2778-2784.
82. Nickerson E., Greenberg F., Keating M.T., McCaskill C., Shaffer L.G. Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet 1995, 56:1156-1161.
83. Tassabehji M., Metcalfe K., Donnai D., Hurst J., Reardon W., Burch M., et al. Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum Mol Genet 1997, 6:1029-1036.
84. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393:276-280.
85. Pehlivan T., Pober B.R., Brueckner M., Garrett S., Slaugh R., Van Rheeden R., et al. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet 1999, 83:201-206.
86. Wat M.J., Shchelochkov O.A., Holder A.M., Breman A.M., Dagli A., Bacino C., et al. Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A 2009, 149A:1661-1677.
87. Barber J.C., Maloney V.K., Huang S., Bunyan D.J., Cresswell L., Kinning E., et al. 8p23.1 duplication syndrome; a novel genomic condition with unexpected complexity revealed by array CGH. Eur J Hum Genet 2008, 16:18-27.
88. Soemedi R., Wilson I.J., Bentham J., Darlay R., Töpf A., Zelenika D., et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 2012, 91:489-501.
89. Greenway S.C., Pereira A.C., Lin J.C., DePalma S.R., Israel S.J., Mesquita S.M., et al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009, 41:931-935.
90. Brunetti-Pierri N., Berg J.S., Scaglia F., Belmont J., Bacino C.A., Sahoo T., et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008, 40:1466-1471.
91. Soemedi R., Topf A., Wilson I.J., Darlay R., Rahman T., Glen E., et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012, 21:1513-1520.
92. Luo C., Yang Y.-F., Yin B.-L., Chen J.-L., Huang C., Zhang W.-Z., et al. Microduplication of 3p25.2 encompassing RAF1 associated with congenital heart disease suggestive of Noonan syndrome. Am J Med Genet 2012, 158A:1918-1923.
93. Nillesen W.M., Yntema H.G., Moscarda M., Verbeek N.E., Wilson L.C., Cowan F., et al. Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome. Hum Mutat 2011, 32:853-859.
94. Koolen D.A., Kramer J.M., Neveling K., Nillesen W.M., Moore-Barton H.L., Elmslie F.V., et al. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat Genet 2012, 44:639-641.
95. Mefford H.C., Sharp A.J., Baker C., Itsara A., Jiang Z., Buysse K., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008, 359:1685-1699.
96. Chen J.L., Zhu X., Zhao T.L., Wang J., Yang Y.F., Tan Z.P. Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11. Mol Cytogenet 2014, 7:28.
97. Glessner J., Bick A.G., Ito K., Homsy J., Rodriguez-Murillo L., Fromer M., et al. Increased Frequency of de novo copy number variations in congenital heart disease by integrative analysis of SNP array and exome sequence data. Circ Res 2014, 115:884-896.
98. Warburton D., Ronemus M., Kline J., Jobanputra V., Williams I., Anyane-Yeboa K., et al. The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet 2014, 133:11-27.
99. Kajiwara K., Berson E.L., Dryja T.P. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 1994, 264:1604-1608.
100. Merla G., Brunetti-Pierri N., Micale L., Fusco C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum Genet 2010, 128:3-26.
101. Han P., Li W., Lin C.H., Yang J., Shang C., Nurnberg S.T., et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature 2014, 514:102-106.
102. Andersen T.A., Troelsen Kde L., Larsen L.A. Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci 2014, 71:1327-1352.
103. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011, 91:279-288.
104. Santoriello C., Zon L.I. Hooked! Modeling human disease in zebra fish. J Clin Invest 2012, 122:2337-2343.
105. Bonetti M., Paardekooper Overman J., Tessadori F., Noël E., Bakkers J., den Hertog J. Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish. Development 2014, 141:1961-1970.
106. Momenah T.S., El Oakley R., Al Najashi K., Khoshhal S., Al Qethamy H., Bonhoeffer P., et al. Extended application of percutaneous pulmonary valve implantation. J Am Coll Cardiol 2009, 53:1859-1863.
107. Momenah T.S., Eltayb H., Oakley R.E., Qethamy H.A., Faraidi Y.A., et al. Effects of transcatheter closure of Fontan fenestration on exercise tolerance. Pediatr Cardiol 2008, 29:585-588.
108. Kelly M., Semsarian C. Multiple mutations in genetic cardiovascular disease: a marker of disease severity?. Circ Cardiovasc Genet 2009, 2:182-190.
109. Al-Aama J.Y., Al-Ghamdi S., Bdier A.Y., Alqarawi A., Jiman O.A., Al-Aama N., et al. Genotype-phenotype analysis of Jervell and Lange-Nielsen syndrome in six families from Saudi Arabia. Clin Genet 2013, 10.1111/cge.12330.
110. Al-Aama J.Y., Al-Ghamdi S., Bdier A.Y., Wilde A.A., Bhuiyan Z.A. De novo mutation in the KCNQ1 gene causal to Jervell and Lange-Nielsen syndrome. Clin Genet 2014, 86:492-495.
111. Bhuiyan Z.A., Alswaid A., Belfiore M., Al-Ghamdi S.S., Liang J., Schlaepffer J. Not all pathogenic mutations are pathogenic: KCNH2 mutations in two sisters with tetralogy of Fallot. Int J Cardiol 2014, 172:276-277.
112. Bhuiyan Z.A., Al-Shahrani S., Al-Aama J., Wilde A.A., Momenah T.S. Congenital long QT syndrome: an update and present perspective in Saudi Arabia. Front Pediatr 2013, 1:39.
113. Bhuiyan Z.A., Al-Shahrani S., Al-Khadra A.S., Al-Ghamdi S., Al-Khalaf K., Mannens M.M., et al. Clinical and genetic analysis of long QT syndrome in children from six families in Saudi Arabia: are they different?. Pediatr Cardiol 2009, 30:490-501.
114. Bhuiyan Z.A., Momenah T.S., Gong Q., Amin A.S., Ghamdi S.A., Carvalho J.S., et al. Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation. Heart Rhythm 2008, 5:553-561.
115. Bhuiyan Z.A., Momenah T.S., Amin A.S., Al-Khadra A.S., Alders M., Wilde A.A., et al. An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome. Prog Biophys Mol Biol 2008, 98:319-327.